More directly, in vivo studies have shown that co-expression of CX3CL1 and CX3CR1 led to a more malignant tumor phenotype with increased microglia/macrophage infiltration and microvessel density, and shorter overall survival [42]. The gene discussed is CX3CL1; the disease is neoplasm.